Stocklytics Platform
Asset logo for symbol TMO
Thermo Fisher Scientific
TMO50
$607.14arrow_drop_up2.12%$12.64
S&P500
Asset logo for symbol TMO
TMO50

$607.14

arrow_drop_up2.12%

Performance History

Chart placeholder
Key Stats
Open$600.53
Prev. Close$594.50
EPS16.09
Next Earnings Date-
Dividend Yield %-
LOWHIGH
Day Range599.29
614.64
52 Week Range415.60
614.64
Ratios
EPS16.09

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•
•

Correlated Companies

Asset logo for symbol LLY
Eli Lilly & Co
LLY74
Price$804.62
Perf. (24h)
arrow_drop_down2.01%-$16.57
Market Cap$738.87B
Asset logo for symbol UNH
UnitedHealth Group
UNH71
Price$569.71
Perf. (24h)
arrow_drop_up1.79%$10.03
Market Cap$527.83B
Asset logo for symbol JNJ
Johnson & Johnson
JNJ62
Price$160.64
Perf. (24h)
arrow_drop_up0.62%$1.00
Market Cap$382.01B
Asset logo for symbol ABBV
AbbVie
ABBV62
Price$185.16
Perf. (24h)
arrow_drop_up1.64%$2.99
Market Cap$326.96B

About Thermo Fisher Scientific (TMO)

Thermo Fisher Scientific Inc. (TMO) is a global leader in serving science. The company offers a comprehensive range of products and services, including analytical instruments, reagents, consumables, software, and services for research, analysis, discovery, and diagnostics. With a mission to enable customers to make the world healthier, cleaner, and safer, Thermo Fisher Scientific is committed to advancing scientific knowledge and improving human health. The company operates in four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Thermo Fisher Scientific has a strong financial position and impressive growth trajectory, with consistent revenue and earnings growth over the years. The company has a market cap of over $200 billion and has consistently outperformed the broader industry. Thermo Fisher Scientific's stock price has seen substantial growth and is currently trading near its 52-week high range. The company's PEG ratio indicates a favorable valuation, suggesting that the stock may be undervalued compared to its earnings growth potential.
Websitecall_made
Sector
Healthcare
Industry
Diagnostics & Research
CEO
Mr. Marc N. Casper
Headquarters
Waltham
Employees
130000
Exchange
NYSE
add Thermo Fisher Scientific to watchlist

Keep an eye on Thermo Fisher Scientific

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is Thermo Fisher Scientific 's (TMO) price per share?
The current price per share for Thermo Fisher Scientific (TMO) is $607.14. The stock has seen a price change of $12.64 recently, indicating a 2.13% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for Thermo Fisher Scientific (TMO)?
For Thermo Fisher Scientific (TMO), the 52-week high is $614.64, which is 1.24% from the current price. The 52-week low is $415.6, the current price is 46.09% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is Thermo Fisher Scientific (TMO) a growth stock?
Thermo Fisher Scientific (TMO) has shown an average price growth of 0.41% over the past three years. It has received a score of 65 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Thermo Fisher Scientific as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is Thermo Fisher Scientific (TMO) stock price performance year to date (YTD)?
As of the latest data, Thermo Fisher Scientific (TMO) has a year-to-date price change of 11.58%. Over the past month, the stock has experienced a price change of 9.1%. Over the last three months, the change has been 6.19%. Over the past six months, the figure is 12.81%. Looking at a longer horizon, the five-year price change stands at 108.93%.
help
Is Thermo Fisher Scientific (TMO) a profitable company?
Thermo Fisher Scientific (TMO) has a net income of $6B, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 40.98% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 17.38% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $42.86B, although specific revenue growth data is currently not available. The gross profit is $17.56B. Operating income is noted at $6.86B. Furthermore, the EBITDA is $11.72B.
help
What is the market capitalization of Thermo Fisher Scientific (TMO)?
Thermo Fisher Scientific (TMO) has a market capitalization of $231.67B. The average daily trading volume is 1.94M, indicating the stock's liquidity and investor engagement.

News

Microbial Detection Systems Market Insights and Forecast, 2024-2032 - BD, Danaher, Thermo Fisher Scientific, bioMerieux, QIAGEN, and Shimadzu Account for ~44% Total Market Share
MICROBIAL DETECTION SYSTEMS
MARKET FORECAST
KEY PLAYERS
MARKET DRIVERS
7/26/2024

Microbial Detection Systems Market Insights and Forecast, 2024-2032 - BD, Danaher, Thermo Fisher Scientific, bioMerieux, QIAGEN, and Shimadzu Account for ~44% Total Market Share

Wafer Process Control Equipment Market, is Projected to hit USD 14.06 Billion in 2032, and is Driven by the Need for Higher Chip Quality and Production Efficiency | Report by SNS Insider
WAFER PROCESS CONTROL EQUIPMENT
SEMICONDUCTOR INDUSTRY
PRODUCTION EFFICIENCY
CHIP QUALITY
7/26/2024

Wafer Process Control Equipment Market, is Projected to hit USD 14.06 Billion in 2032, and is Driven by the Need for Higher Chip Quality and Production Efficiency | Report by SNS Insider

Thermo Fisher (TMO) Beats on Q2 Earnings, Raises 2024 EPS View - Zacks Investment Research
THERMO FISHER SCIENTIFIC
EARNINGS
REVENUE
MARGIN
LIFE SCIENCES SOLUTIONS
LABORATORY PRODUCTS AND BIOPHARMA SERVICES
7/24/2024

Thermo Fisher (TMO) Beats on Q2 Earnings, Raises 2024 EPS View - Zacks Investment Research

Thermo Fisher Q2 Earnings: Marginal Revenue Dip, Completes Olink Acquisition, Lifts Annual Profit Outlook - Benzinga
THERMO FISHER SCIENTIFIC
OLINK
CONTRACT DRUG MANUFACTURERS
BIOTECH
INTEREST RATES
7/24/2024

Thermo Fisher Q2 Earnings: Marginal Revenue Dip, Completes Olink Acquisition, Lifts Annual Profit Outlook - Benzinga

Global Cell Culture Media Market Set to Reach USD 6,699.93 - GlobeNewswire
CELL CULTURE MEDIA
BIOPHARMACEUTICALS
RESEARCH
VACCINES
TREATMENTS
PERSONALIZED THERAPIES
7/24/2024

Global Cell Culture Media Market Set to Reach USD 6,699.93 - GlobeNewswire

Antimicrobial Resistance Surveillance Market Size to Hit - GlobeNewswire
ANTIMICROBIAL RESISTANCE
SURVEILLANCE
DRUG-RESISTANT INFECTIONS
MARKET GROWTH
7/22/2024

Antimicrobial Resistance Surveillance Market Size to Hit - GlobeNewswire

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level